DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Rolziracetam
Rolziracetam
United States Patent 19 11 Patent Number: 5,439,930 Seredenin Et Al
(12) United States Patent (10) Patent No.: US 6,264,917 B1 Klaveness Et Al
Council on Science and Public Health Reports
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
Federal Register / Vol. 60, No. 80 / Wednesday, April 26, 1995 / Notices DIX to the HTSUS—Continued
Stembook 2018.Pdf
Medicines Regulations 1984 (SR 1984/143)
Psychoactive Medications Grouped by Drug Class and Foods Studied Tor Psychoactive Effects
Poisons Standard February 2020
Ep 2288345 B1
(12) United States Patent (10) Patent No.: US 6,746,678 B1 Shapiro (45) Date of Patent: *Jun
Harmonized Tariff Schedule of the United States (2004) -- Supplement 1 Annotated for Statistical Reporting Purposes
2. Review of Literature Chapter-! ^View of Citerature
Marrakesh Agreement Establishing the World Trade Organization
Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs
Drugs Affecting the Central Nervous System
Racetam Candidates Based on “Pyrrolidone” Dimers By: Robert B
REPORT 9 of the COUNCIL on SCIENCE and PUBLIC HEALTH (A-16) Increasing Awareness of Nootropic Use (Reference Committee E)
Top View
Substance Abuse in the Workplaces of Our Bodies and Mind
Piracetam and Aniracetam Antagonism of Centrally Active
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
Classification Status of Racetams
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
Harmonized Tariff Schedule of the United States (2006) (Rev
Learning Disorders (PDF)
(12) Patent Application Publication (10) Pub. No.: US 2009/017674.0 A1 Phillips, II (43) Pub
Publication of Interim Decisions Proposing to Amend, Or Not Amend, the Current Poisons Standard, February 2019
Introduction
Identification of Applicable 6-Digit HS Subheadings for Products Covered by the Proposed Uruguay Round Pharmaceutical Agreement
Poisons Standard June 2021
The Novel Nootropic Compound DM232 (UNIFIRAM)